3 completed, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Neurotrope Bioscience, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bryostatin Treatment of Moderately Severe Alzheimer's Disease Bryostatin 1, Placebo - Alzheimer Disease | Phase 2 | Completed | Neurotrope Bioscience, Inc. | 122 | 2020-08-30 | 2024-07-31 |
| A Study of Bryostatin in Moderately Severe to Severe Alzheimer's Disease Subjects Not On Memantine Bryostatin, Placebo - Alzheimer Disease | Phase 2 | Completed | Neurotrope Bioscience, Inc. | 108 | 2018-06-20 | 2020-10-01 |
| A Study Assessing Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease Bryostatin 1, Placebo - Alzheimer's Disease | Phase 2 | Completed | Neurotrope Bioscience, Inc. | 147 | 2015-11-01 | 2018-07-06 |
| Study to Evaluate the Preliminary Safety, Efficacy, PK and PD of Bryostatin 1 in Patients With Alzheimer's Disease Bryostatin 1, Placebo - Alzheimer's Disease | Phase 1 / Phase 2 | Terminated | Neurotrope Bioscience, Inc. | 9 | 2014-06-01 | 2017-11-06 |
bryostatin 1 (3) · Bryostatins (2)
United States (4)
Alan Tuchman, MD (1) · Hakop Gevorkyan, MD, MBA (1)
R44AG066366 (1)